HLVX Archived Articles
HilleVax (HLVX): Navigating the Challenges of Norovirus Vaccine Development
Published on March 15, 2025
HilleVax (NASDAQ:HLVX) Faces Setback as Norovirus Vaccine Trial in Infants Fails, But Adult Opportunity Remains
Published on September 24, 2024